Skip to Main Content

Author Details

Shekhar Ghamande
Texas A&M University College of Medicine
1995
133
32
PMIDPaper TitleJournal TitlePublished Year
36758420Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.Gynecol Oncol2023
37862814High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.Gynecol Oncol2023
37666539A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.Int J Gynecol Cancer2023
37796753Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged â¿¥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.MMWR Morb Mortal Wkly Rep2023
37651655Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.J Clin Oncol2023
37724234Systemic Venous Congestion Reviewed.Cureus2023
35580849Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.Clin Infect Dis2023
37326325Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults.N Engl J Med2023
37126016Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.Clin Cancer Res2023
37060236Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.Cancer2023
36993496Protocol and statistical analysis plan for the PREOXI trial of preoxygenation with noninvasive ventilation vs oxygen mask.medRxiv2023
37457916Prophylactic Administration of Vasopressors Prior to Emergency Intubation in Critically Ill Patients: A Secondary Analysis of Two Multicenter Clinical Trials.Crit Care Explor2023
37255285Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.Clin Infect Dis2023
37381977A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.Future Oncol2023
37104244Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.MMWR Morb Mortal Wkly Rep2023
37074254Defining Successful Intubation on the First Attempt Using Both Laryngoscope and Endotracheal Tube Insertions: A Secondary Analysis of Clinical Trial Data.Ann Emerg Med2023
37334099The role of supervised school therapy in poorly controlled asthma in children.Proc (Bayl Univ Med Cent)2023
37301704Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.Vaccine2023
37363992Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.Clin Cancer Res2023
37065558The role of the RAPID score in surgical planning for empyema.J Thorac Dis2023
37028995Laryngoscopy and Tracheal Intubation: Does Use of a Video Laryngoscope Facilitate Both Steps of the Procedure?Ann Emerg Med2023
36883903Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.J Infect Dis2023
36694363Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study.Clin Infect Dis2023
36434945Pharmacogenetics as a predictor chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy.Gynecol Oncol2023
34320171Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).Clin Infect Dis2022
35707974Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial.JAMA2022
35675695Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.Clin Infect Dis2022
35658487A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).J Clin Oncol2022
35385875mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.J Infect Dis2022
36695662Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.Open Forum Infect Dis2022
36580424Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged â¿¥65 Years - IVY Network, 18 States, September 8-November 30, 2022.MMWR Morb Mortal Wkly Rep2022
36264830Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.MMWR Morb Mortal Wkly Rep2022
36055814Clinical calculator redefines prognosis for high-risk early-stage ovarian cancers and potential to guide treatment in the adjuvant setting.Gynecol Oncol2022
35917514Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial.Clin Cancer Res2022
36374708Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.Vaccine2022
33753870Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer.Cancer Gene Ther2022
35064011Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.J Immunother Cancer2022
35085218Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.MMWR Morb Mortal Wkly Rep2022
34932114Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.J Infect Dis2022
35265255Pleomorphic high grade endometrial stromal sarcoma with <i>YWHAE</i> gene amplification may be a novel variant with poor prognosis.Int J Clin Exp Pathol2022
35264324Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.BMJ2022
35324878Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.MMWR Morb Mortal Wkly Rep2022
34645648Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study.Clin Cancer Res2022
33155151Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?Ann Surg Oncol2021
33520368Tumor-intrinsic and -extrinsic (immune) gene signatures robustly predict overall survival and treatment response in high grade serous ovarian cancer patients.Am J Cancer Res2021
33678966Unilateral pulmonary edema and acute severe mitral regurgitation associated with operatively repaired aortic coarctation.Proc (Bayl Univ Med Cent)2021
33687930Subclavian artery aneurysm: a rare cause of massive haemoptysis.BMJ Case Rep2021
34734975Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.JAMA2021
34732985Selection of abstracts from Baylor Scott &amp; White Health Central Texas Scholars Day.Proc (Bayl Univ Med Cent)2021
34619736Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix.Obstet Gynecol2021
  • 1 - 50 of 133

Recommended Authors

Mayo Clinic
Career Start Year 2018
Number of shared co-authors 0
Weill Cornell Medical College
Career Start Year 2017
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 0
University of Arizona
Career Start Year 2011
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 3
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 2
Amsterdam Institute for Infection and Immunity (AII), Vrije Universiteit
Career Start Year 2009
Number of shared co-authors 0
Mayo Clinic Alix School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Taipei Veterans General Hospital
Career Start Year 2007
Number of shared co-authors 0
Cork University Hospital
Career Start Year 2006
Number of shared co-authors 0
Universite Paris-Cite, INSERM
Career Start Year 2006
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 2
University of Texas at Houston Health Science Center
Career Start Year 2002
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 0
Chonbuk National University Hospital
Career Start Year 1998
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Wonju Severance Christian Hospital
Career Start Year 1993
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 1
Kumaun University
Career Start Year 1992
Number of shared co-authors 0
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1985
Number of shared co-authors 0
Rollins School of Public Health, Emory University School of Medicine
Career Start Year 1984
Number of shared co-authors 2
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Vanderbilt University Medical Center
Co-authored papers 25
Wake Forest University
Co-authored papers 25
University of Colorado School of Medicine
Co-authored papers 23
Oregon Health and Science University
Co-authored papers 23
Hennepin County Medical Center
Co-authored papers 22
University of Michigan School of Public Health ann arbor
Co-authored papers 20
Baylor Scott & White Health and Baylor College of Medicine
Co-authored papers 20
Vanderbilt University Medical Center
Co-authored papers 20
Vanderbilt University Medical Center
Co-authored papers 19
Baylor College of Medicine
Co-authored papers 19
University of Michigan ann arbor
Co-authored papers 19
Johns Hopkins University
Co-authored papers 18
Ohio State University Wexner Medical Center
Co-authored papers 18
Vanderbilt University Medical Center
Co-authored papers 18
University of Miami
Co-authored papers 18
Vanderbilt University Medical Center
Co-authored papers 18
Intermountain Medical Center and University of Utah
Co-authored papers 18
University of Massachusetts Medical School - Baystate
Co-authored papers 18
Washington University School of Medicine
Co-authored papers 18
Albert Einstein College of Medicine
Co-authored papers 17
Beth Israel Deaconess Medical Center
Co-authored papers 17
University of California los angeles
Co-authored papers 17
Vanderbilt University Medical Center
Co-authored papers 17
David Geffen School of Medicine at university of california los angeles
Co-authored papers 17
University of Iowa Carver College of Medicine
Co-authored papers 17
Vanderbilt University Medical Center
Co-authored papers 17
Cleveland Clinic
Co-authored papers 16
Albert Einstein College of Medicine
Co-authored papers 16
Vanderbilt University Medical Center
Co-authored papers 16
Texas A&M University College of Medicine
Co-authored papers 16